Detecting EGFR mutations and ALK /ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples
Author:
Affiliation:
1. Cancer Center; Renmin Hospital of Wuhan University; Wuhan China
2. State Key Laboratory of Virology; College of Life Sciences, Wuhan University; Wuhan China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12932/fullpdf
Reference25 articles.
1. Management of malignant pleural effusions;Antony;Eur Respir J,2001
2. Diagnostic value of medical thoracoscopy in malignant pleural effusion;Wu;BMC Pulm Med,2017
3. EGFR mutations in malignant pleural effusions from lung cancer;Shamblin;Curr Respir Care Rep,2013
4. Aptamer-polymer functionalized silicon nanosubstrates for enhanced recovered circulating tumor cell viability and in vitro chemosensitivity testing;Shen;Int J Nanomedicine,2016
5. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials;NSCLC Meta-Analyses Collaborative Group;J Clin Oncol,2008
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Profiling Cell-Free DNA from Malignant Pleural Effusion for Oncogenic Driver Mutations in Patients with Treatment-Naive Stage IV Adenocarcinoma: A Multicenter Prospective Study;Molecular Diagnosis & Therapy;2024-08-15
2. Biomarkers of respiratory diseases;Biological Insights of Multi-Omics Technologies in Human Diseases;2024
3. Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non‐small cell lung cancer;Diagnostic Cytopathology;2023-04-20
4. Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer;Beilstein Journal of Nanotechnology;2023-02-22
5. Clinical Application of Blocker Displacement Amplification Technique Combined with Next Generation Sequencing in Liquid Biopsy of Advanced Non-Small Cell Lung Cancer with Positive Anaplastic Lymphoma Kinase and Repressor of Silencing 1 Fusion Genes;J BIOL REG HOMEOS AG;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3